Agness Jonathan

Dr. Agness Jonathan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
AJAgnes Jonathan
Agnes Jonathan
HTHilda Tutuba
Hilda Tutuba
WLWilliam Lloyd
William Lloyd
JNJoyce Ndunguru
Joyce Ndunguru
JMJulie Makani
Julie Makani
EBEmmanuel Balandya
Emmanuel Balandya
Background: Sickle cell disease (SCD) is a global public health priority due to its high morbidity and mortality. In Tanzania, SCD accounts for 7% of under-five mortality. Cost-effective interventions such as early diagnosis and linkage to care have been shown to prevent 70% of deaths but require knowledge among healthcare workers and availability of resources at health facilities. In Tanzania, data on these critical determinants are currently lacking.Objective: To assess healthcare workers’ knowledge and resource availability for care of SCD at health facilities in Dar es Salaam, Tanzania.Methodology: A facility-based cross-sectional study was conducted between December 2020 and February 2021 among 490 nurses and clinicians at Regional Referral Hospitals (Temeke, Amana, and Mwananyamala) and Muhimbili National Hospital in Dar es Salaam, Tanzania. Data were collected using a pre-tested structured questionnaire consisting of 13 knowledge questions (scored good knowledge if correct response in >7) and an inventory check list to record available resources. Pearson’s χ2 was used to determine the association between level of knowledge and demographic factors. Multivariate logistic regression was used to ascertain the strength of associations. A two-tailed p-value <0.05 was considered to be statistically significant.Results: Of the 490 participants (median age 28 years [IQR = 26–35]), only 25.1% had good knowledge on SCD. The odds of good knowledge was 82% lower in nurses than clinicians (AOR = 0.177; 95% CI: 0.090, 0.349; p < 0.001); 95% lower in diploma than Master’s degree holders (AOR = 0.049; 95% CI: 0.008, 0.300; p = 0.001) and 4.6 times higher in those with 5–9 years than ≥10 years of experience (AOR = 4.564; 95% CI: 1.341, 15.525; p = 0.015). The regional-level hospitals lacked diagnostic tests and hydroxyurea therapy.Conclusion: There was general lack of knowledge on SCD among healthcare workers and limited availability of critical resources for the diagnosis and care of SCD, especially at regional-level hospitals. Efforts are needed for their improvement to enhance care to patients, thus reducing the morbidity and mortality due to SCD in Tanzania.

28 November 2021 in Hemato
Verified
Journal Article
Open access
PDF file
MKManase Kilonzi
Manase Kilonzi
Hamu Joseph MlyukaHamu Joseph Mlyuka
Hamu Joseph Mlyuka
FFFatuma Felix
Fatuma Felix
DMDorkasi L. Mwakawanga
Dorkasi L. Mwakawanga
LCLulu Chirande
Lulu Chirande
NSNathanael Sirili
Nathanael Sirili
Factors contributing to low use of HU among SCD patients exist in high-income countries. The latter leaves a drift of literature on factors for low utilization of HU in developing countries. This study aimed to explore the factors influencing the use of HU in the management of SCD in Tanzania. A qualitative study was employed to interview purposively selected participants for this study. The in-depth interviews were conducted with 11 parents of children with SCD, four medical doctors working at sickle cell clinics, and two representatives of the national health insurance fund (NHIF). Interviews were audio-recorded, transcribed, and thematically analysed. Barriers identified were misconception of parents on SCD, financial constraints, regulatory restrictions, worries and fears of medical doctors on the acceptability of HU, shortages of laboratory equipment and consumables, and limited availability of HU. Adequate knowledge of the parents and medical doctors on SCD and HU and opportunities for HU accessibility were the facilitators identified. The utilization of HU by the individual with SCD is affected by several factors, from individual to policy level. Nevertheless, parents of children with SCD and medical doctors working in sickle cell clinics demonstrated good knowledge of the diseases and HU.

MKManase Kilonzi
Manase Kilonzi
DMDorkasi L. Mwakawanga
Dorkasi L. Mwakawanga
FFFatuma Felix
Fatuma Felix
Hamu Joseph MlyukaHamu Joseph Mlyuka
Hamu Joseph Mlyuka
LCLulu Chirande
Lulu Chirande
NSNathanael Sirili
Nathanael Sirili
Tanzania is among the top five countries with a high burden of sickle cell disease (SCD) in the world. Even though the effects of SCD on quality of life have been documented in other countries including Nigeria and the United States of America, few are known from Tanzania. Therefore, this study focused on evaluating the effects of SCD on the quality of life among children living with SCD and their parents. The study employed a qualitative approach to interview purposively selected parents of children who have lived with SCD and have used hydroxyurea (HU) for more than 3 years. The in-depth interviews were conducted with 11 parents of children with SCD at the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar-es-salaam, Tanzania. A semi-structured interview guide was used. Interviews were audio-recorded, transcribed, and thematically analyzed. Three themes were generated including psycho-social effects: family conflicts and divorce, limited access to education, stress and fear; financial effects: Employment limitation, reduced efficiency and productivity, loss of job and lack of self-keeping expenses; and physical effects: physical disability and dependence, and burden of the frequent crisis. Children living with SCD and their parents suffer psycho-social, financial, and physical impacts of the disease. Appropriate interventions should be introduced to minimize the observed effects as ways of improving the quality of life of the individuals living with SCD and their caregivers.

7 November 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Hamu Joseph MlyukaHamu Joseph Mlyuka
Hamu Joseph Mlyuka
MKManase Kilonzi
Manase Kilonzi
RMRitah Mutagonda
Ritah Mutagonda
LCLulu Chirande
Lulu Chirande
Wigilya P MikomangwaWigilya P Mikomangwa
Wigilya P Mikomangwa
AKAppolinary A. R. Kamuhabwa
Appolinary A. R. Kamuhabwa
Despite three decades of proven safety and effectiveness of hydroxyurea in modifying sickle cell disease (SCD), its accessibility is limited in Sub-Saharan Africa, which shares 75% of the world’s SCD burden. Therefore, it is time to explore the barriers and facilitators for manufacturing and importation of hydroxyurea for SCD in Tanzania. This was qualitative research that employed a case study approach. Purposive sampling followed by an in-depth interview (IDI) using a semi-structured questionnaire aspired by data saturation enabled us to gather data from 10 participants. The study participants were people with more than three years of experience in pharmaceuticals importation, manufacturing, and regulation. The audio-recorded data were verbatim transcribed and analyzed using thematic analysis. Two themes were generated. The first comprised barriers for importation and manufacturing of hydroxyurea with sub-themes such as inadequate awareness of SCD and hydroxyurea, limited market, and investment viability. The second comprised opportunities for importation and manufacturing of hydroxyurea with sub-themes such as awareness of activities performed by medicines regulatory authority and basic knowledge on SCD and hydroxyurea. Inadequate understanding of SCD, hydroxyurea, and orphan drug regulation are major issues that aggravate the concern for limited market and investment viability. Existing opportunities are a starting point towards increasing the availability of hydroxyurea.

15 April 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GKGibson Benard Kagaruki
Gibson Benard Kagaruki
PKPeter Mathias Karoli
Peter Mathias Karoli
WRWillfredius M. Rutahoile
Willfredius M. Rutahoile
PCPilly Chillo
Pilly Chillo
RMReuben Mutagaywa
Reuben Mutagaywa
MMMary Theodory Mayige
Mary Theodory Mayige
Background: Non-communicable diseases (NCDs) have increased significantly in Tanzania, accounting for 33% of mortality in the country. Having adequate knowledge translated into practice has a significant effect on the health of individuals through adoption of positive behaviours and influencing better health seeking behaviours. For those already affected by NCDs, it promotes secondary and tertiary prevention by helping them effectively cope with the disease. In this study, we aimed to determine the level and determinants of NCDs knowledge in the community to inform the implementation of WHO PEN- Plus initiatives. Methods: This cross-sectional study was conducted from May to June 2023 involving 528 adults aged 25–64 years from two purposely selected districts and 11, 22 and 528 randomly selected wards, villages, and households respectively. Information on socio-economic, demographic, NCDs knowledge were collected from each participant. Chi-square test and Modified Poisson Regression were applied to assess the association and determinants of NCDs knowledge level. Results: The median age of study participants was 40.5 years. Less than half 42.6%(n=225) were aware of the term NCD and less than one third were aware of the NCD conditions such as Type 1 Diabetes Mellitus (T1DM) 15.3%(n=70), Sickle Cell Disease (SCD) 25.2%(n=133), Rheumatic fever 28.6%(n=151) and Heart failure 33.1%(n=175). Good level of awareness was reported on Type 2 Diabetes Mellitus (T2DM) 79.5%(n=364). More than three quarters of the respondents had low knowledge on T1DM (90.3%), SCD (84.1%), Rheumatic fever (81.3%), NCDs (80.5%) and Heart failure (76.1%). Furthermore, more than half (56.4%) of respondents had low knowledge for T2DM. Adjusted analysis indicated that, for all NCDs except SCD, low knowledge was significantly associated with the district of residence (Kondoa). Low knowledge of NCDs, T2DM, and SCD was significantly associated with having no education, or having only primary or secondary education. Individuals from the lowest, second, middle, and fourth socio-economic status families were significantly associated with low knowledge of NCDs, while the lowest and fourth socio-economic status levels were associated with low knowledge of T2DM and SCD. Conclusion: Low knowledge was observed for all NCDs conditions and socio-economic and demographic characteristics were associated with low knowledge. Interventions to increase NCDs knowledge should consider the socio-economic determinants.

20 May 2022 in F1000Research
Verified
Journal Article
Open access
PDF file
MKManase Kilonzi
Manase Kilonzi
HMHamu Mlyuka
Hamu Mlyuka
AJAgnes Jonathan
Agnes Jonathan
HTHilda Tutuba
Hilda Tutuba
LCLulu Chirande
Lulu Chirande
NSNathanael Sirili
Nathanael Sirili
Hydroxyurea (HU) alone has the potential to prevent one out of every three deaths due to sickle cell disease (SCD) and almost all forms of disabilities caused by SCD. However, in Tanzania, only one out of every six registered SCD patients in the SPARCO-Tanzania Sickle Cell Cohort use HU. We conducted studies to understand factors influencing utilization of HU in Tanzania and discovered that among the reason for low utilization of HU include HU is classified as anticancer medication, only hematologists are supposed to prescribe HU, limited HU prescription to only National and Specialized hospitals, a special permit is required to access HU using National Health Insurance Fund (NHIF) scheme and limited importation and absence of local manufacturing of HU limit availability of this important drug in Tanzania. Therefore, with this brief, the government should allow prescription of HU to the district hospitals level, should allow all clinicians with a minimum of a Bachelor of Medicine to prescribe HU, and accessibility of HU through NHIF should be friendly.